Also, Alastair McEwan, chairman of the board of Cornerstone BioPharma, has been appointed to the board of directors of Cornerstone Therapeutics. Concurrently, Cornerstone Therapeutics also appointed three independent directors to its board: Christopher Codeanne, Michael Enright and Michael Heffernan.
Mr Collard said: “I look forward to working closely with my fellow board members to create a leading specialty pharmaceutical company. Their diverse financial management and pharmaceutical industry backgrounds will provide us with valuable insight and experience as we continue growing our business.”